Brief Cognitive Behavioral Therapy for People With Physical Disabilities

Sponsor

Ohio State University (Other)

Overall Status

Recruiting

CT.gov ID

NCT05695430

Collaborator

American Foundation for Suicide Prevention (Other)

Enrollment

Location

Arm

Anticipated Duration (Months)

2.5

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to examine the effectiveness of a psychotherapy (non-medication) treatment, Brief Cognitive Behavioral Therapy for Suicide Prevention, in reducing suicide ideation and attempts for people with physical disabilities.

Condition or Disease	Intervention/Treatment	Phase
Suicide Suicide, Attempted Suicidal Ideation Disability Physical Disability Hearing Disability, Vision	Behavioral: Brief Cognitive Behavioral Therapy for People with Physical Disabilities	N/A

Study Design

Study Type:

Interventional

Anticipated Enrollment :

60 participants

Allocation:

N/A

Intervention Model:

Sequential Assignment

Masking:

None (Open Label)

Primary Purpose:

Treatment

Official Title:

Telehealth-delivered Brief Cognitive Behavioral Therapy to Prevent Suicides in People With Physical Disabilities

Actual Study Start Date :

Mar 1, 2022

Anticipated Primary Completion Date :

Feb 1, 2024

Anticipated Study Completion Date :

Mar 1, 2024

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Brief Cognitive Behavioral Therapy for People with Physical Disabilities	Behavioral: Brief Cognitive Behavioral Therapy for People with Physical Disabilities 12 sessions of of Brief Cognitive Behavioral Therapy that has been adapted for people with physical disabilities will be administered through telehelath.

Arm

Intervention/Treatment

Experimental: Brief Cognitive Behavioral Therapy for People with Physical Disabilities

Behavioral: Brief Cognitive Behavioral Therapy for People with Physical Disabilities

12 sessions of of Brief Cognitive Behavioral Therapy that has been adapted for people with physical disabilities will be administered through telehelath.

Outcome Measures

Primary Outcome Measures

Scaler for Suicide Ideation [Weekly change through treatment completion, an average of 3 months]
Past-week suicidal ideation severity

Secondary Outcome Measures

Self-Injurious Thoughts and Behaviors Interview-Revised [Through treatment completion, an average of 3 months]
Suicide attempt since last assessment

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

18 years of age
Disability impacting vision, hearing, or mobility
Past-week suicidal ideation or past-month suicide attempt

Exclusion Criteria:

Inability to provide informed consent
Lack of internet connection and web camera

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	The Ohio State Universitty Wexner Medical Center	Columbus	Ohio	United States	43214

Sponsors and Collaborators

Ohio State University
American Foundation for Suicide Prevention

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Lauren Khazem, Research Assistant Professor, Ohio State University

ClinicalTrials.gov Identifier:

NCT05695430

Other Study ID Numbers:

2021B0340

First Posted:

Jan 25, 2023

Last Update Posted:

Jan 25, 2023

Last Verified:

Jan 1, 2023

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 25, 2023